ATEC vs. LMNX, GNMK, MDXG, LMAT, KIDS, MASI, ITGR, IART, ATRC, and OFIX
Should you be buying Alphatec stock or one of its competitors? The main competitors of Alphatec include Luminex (LMNX), GenMark Diagnostics (GNMK), MiMedx Group (MDXG), LeMaitre Vascular (LMAT), OrthoPediatrics (KIDS), Masimo (MASI), Integer (ITGR), Integra LifeSciences (IART), AtriCure (ATRC), and Orthofix Medical (OFIX). These companies are all part of the "medical" sector.
Luminex (NASDAQ:LMNX) and Alphatec (NASDAQ:ATEC) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, dividends, profitability, analyst recommendations, valuation, earnings, institutional ownership and community ranking.
87.8% of Luminex shares are owned by institutional investors. Comparatively, 66.4% of Alphatec shares are owned by institutional investors. 6.6% of Luminex shares are owned by company insiders. Comparatively, 22.8% of Alphatec shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Luminex has a net margin of 5.39% compared to Luminex's net margin of -37.45%. Alphatec's return on equity of 4.66% beat Luminex's return on equity.
In the previous week, Alphatec had 7 more articles in the media than Luminex. MarketBeat recorded 7 mentions for Alphatec and 0 mentions for Luminex. Luminex's average media sentiment score of 0.59 beat Alphatec's score of 0.50 indicating that Alphatec is being referred to more favorably in the news media.
Alphatec received 59 more outperform votes than Luminex when rated by MarketBeat users. Likewise, 56.99% of users gave Alphatec an outperform vote while only 45.28% of users gave Luminex an outperform vote.
Luminex has a beta of 0.56, suggesting that its share price is 44% less volatile than the S&P 500. Comparatively, Alphatec has a beta of 1.4, suggesting that its share price is 40% more volatile than the S&P 500.
Alphatec has a consensus price target of $20.78, indicating a potential upside of 90.45%. Given Luminex's higher possible upside, analysts plainly believe Alphatec is more favorable than Luminex.
Luminex has higher earnings, but lower revenue than Alphatec. Alphatec is trading at a lower price-to-earnings ratio than Luminex, indicating that it is currently the more affordable of the two stocks.
Summary
Alphatec beats Luminex on 9 of the 17 factors compared between the two stocks.
Get Alphatec News Delivered to You Automatically
Sign up to receive the latest news and ratings for ATEC and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ATEC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Alphatec Competitors List
Related Companies and Tools
